Maintenance of cancellous bone in ovariectomized, human parathyroid hormone [hPTH(1-84)]-treated rats by estrogen, risedronate, or reduced hPTH

Bone

Volumn 29, Issue 4, 2001, Pages 352-360

  Iwaniec, U T ^a,b   SamnegArd E ^a   Cullen, D M ^a   Kimmel, D B ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Anabolic bone agent; Bisphosphonate; Densitometry; Histomorphometry; Osteopenia

Indexed keywords

ESTRADIOL; PARATHYROID HORMONE; RISEDRONIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE MINERAL; BONE TURNOVER; CANCELLOUS BONE; CELL SURFACE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FEMUR; HUMAN; MINERALIZATION; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; OVARIECTOMY; RAT; TIBIA;

ANIMALS; BONE DENSITY; BONE DISEASES, METABOLIC; CALCIUM CHANNEL BLOCKERS; DIPHOSPHONATES; ESTROGENS; ETIDRONIC ACID; FEMALE; FEMUR; HUMANS; OSTEOGENESIS; OVARIECTOMY; PARATHYROID HORMONE; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL RATE; TIBIA;

EID: 0034805164     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(01)00582-8     Document Type: Article

References (39)

1. Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats
2. Estrogen dose required to maintain parathyroid hormone mediated bone gain in osteopenic ovariectomized rats is probably higher than in preventive treatment with estrogen
3. Is parathyroid hormone a therapeutic option for osteoporosis? A review of the clinical evidence
4. Anabolic actions of parathyroid hormone on bone
5. Rapid determination of cancellous bone mineral loss in ovariectomized rats by a subtraction technique
6. Estrogen: Prevention and treatment of osteoporosis
7. Loss of the anabolic effect of parathyroid hormone on bone after discontinuation of hormone in rats
8. Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats
9. Resorption is not essential for the stimulation of bone growth by hPTH-(1-34) in rats in vivo
10. Assessment of maintenance therapy with reduced doses of PTH(1-34) in combination with a raloxifene analogue (LY117018) following anabolic therapy in the ovariectomized rat
11. Effects of nicotine on bone and calciotropic hormones in growing female rats
12. Maintaining restored bone with bisphosphonate in the ovariectomized rat skeleton: Dynamic histomorphometry of changes in bone mass
13. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats
14. Effect of clodronate treatment on established bone loss in ovariectomized rats
15. Early estrogen replacement therapy reverses the rapid loss of trabecular bone volume and prevents further deterioration of connectivity in the rat
16. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats
17. Parathyroid hormone monotherapy and cotherapy with antiresorptive agents restore vertebral bone mass and strength in aged ovariectomized rats
18. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis
19. Pre-existing bone loss associated with ovariectomy in rats is reversed by parathyroid hormone
20. Partial maintenance of extra cancellous bone mass by antiresorptive agents after discontinuation of human parathyroid hormone (1-38) in right hindlimb immobilized rats
21. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats
22. Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up)
23. Treatment with PTH peptides
24. Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum
25. Bone histomorphometry: Standardization of nomenclature symbols, and units
26. A comparison of the anabolic effects of parathyroid hormone at skeletal sites with moderate and severe osteopenia in aged ovariectomized rats
27. Maintenance of vertebral body bone mass and strength created by hPTH treatment in ovariectomized rats
28. Maintenance of cortical bone in human parathyroid hormone(1-84) treated osteopenic, ovariectomized rats
29. Alendronate treatment for osteoporosis: A review of the clinical evidence
30. Accretion of bone mass and strength with parathyroid hormone prior to the onset of estrogen deficiency can provide temporary beneficial effects in skeletally mature rats
31. Effect of intermittent administration of parathyroid hormone (1-34) on experimental osteopenia in rats induced by ovariectomy
32. Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats
33. Restoring and maintaining bone in osteopenic female rat skeleton: I. Changes in bone mass and structure
34. Long-term effects of ovariectomy and aging on the rat skeleton
35. PTH: Skeletal effects in the ovariectomized rat model for postmenopausal bone loss
36. Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats
37. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats
38. Maintenance of bone mass by physical exercise after discontinuation of intermittent hPTH (1-34) administration